43
Participants
Start Date
December 31, 2004
Primary Completion Date
May 31, 2007
Study Completion Date
November 30, 2008
capecitabine
Capecitabine will be given 625 mg/m\^2 (1250 mg/m\^2/day) by mouth twice a day on day 1-21 for every cycle (1 cycle =28 days) until disease progression
gemcitabine hydrochloride
Gemcitabine will be given 900 mg/m\^2 by intravenous infusion over 30 minutes on day 1, 8, and 15 for every cycle (1 cycle = 28 days) until disease progression.
National Cancer Institute (NCI)
NIH
SWOG Cancer Research Network
NETWORK